Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Goodwill & Intangibles (2022 - 2024)

Historic Goodwill & Intangibles for Zentalis Pharmaceuticals (ZNTL) over the last 3 years, with Q3 2024 value amounting to $3.7 million.

  • Zentalis Pharmaceuticals' Goodwill & Intangibles changed 0.0% to $3.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $3.7 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.7 million for FY2023, which is 0.0% changed from last year.
  • Zentalis Pharmaceuticals' Goodwill & Intangibles amounted to $3.7 million in Q3 2024, which was down 0.0% from $3.7 million recorded in Q2 2024.
  • In the past 5 years, Zentalis Pharmaceuticals' Goodwill & Intangibles registered a high of $3.7 million during Q1 2022, and its lowest value of $3.7 million during Q1 2022.
  • For the 3-year period, Zentalis Pharmaceuticals' Goodwill & Intangibles averaged around $3.7 million, with its median value being $3.7 million (2022).
  • Examining YoY changes over the last 5 years, Zentalis Pharmaceuticals' Goodwill & Intangibles showed a top increase of 0.0% in 2023 and a maximum decrease of 0.0% in 2023.
  • Over the past 3 years, Zentalis Pharmaceuticals' Goodwill & Intangibles (Quarter) stood at $3.7 million in 2022, then changed by 0.0% to $3.7 million in 2023, then changed by 0.0% to $3.7 million in 2024.
  • Its Goodwill & Intangibles stands at $3.7 million for Q3 2024, versus $3.7 million for Q2 2024 and $3.7 million for Q1 2024.